According to a new report Global Cancer Registry Software Market, published by KBV Research, The Global Cancer Registry Software Market size is expected to reach $90.8 Million by 2025, rising at a market growth of 10.33% CAGR during the forecast period. Increased incidence of cancer and an increasing number of care organizations are among the factors driving the market growth.

TIn the deployment mode segment, the on-premise segment recorded the largest share of the market. Revenue is improved by increasing the implementation of on-premise solutions by hospitals & research institutes owing to their benefits like lower risk of external threats and high security against a data breach. Due to reduced installment charges and IT overhead costs, the cloud-based segment is expected to show lucrative growth during the forecast period.

Because of its data security advantage compared with the public database, the commercial segment dominated the market in terms of revenue share in 2018. Commercial database often adheres to government standards and coding. The Public Cancer Registry Software Market is expected to witness a CAGR of 10.5% during (2019 - 2025).

As of 2018, the government & third party retained the largest share of the end-use segment. Increasing the adoption of this software by governments of developed as well as developing countries to ease the burden of cancer are accelerating market growth. The research institutes segment is anticipated to grow at a lucrative growth rate over the forecast period due to increased research initiatives being undertaken by government and private organizations to address the growing cancer incidence.

The Asia Pacific is anticipated to witness lucrative growth rate of 11.62% during the forecast period as a result of ramping up government initiatives in this region. In addition, the switch of pharmaceutical companies to low-cost manufacturing countries like China and India is further driving Asia Pacific market growth. Owing to the existence of developed infrastructure, North America recorded the largest revenue share on the cancer registry software market in 2018. Increasing cancer incidence in this area due to tobacco smoking and lack of physical activity among others is driving growth in the marketplace. The Europe market is expected to witness a CAGR of 9.9% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/cancer-registry-software-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.

Global Cancer Registry Software Market Segmentation

By Type
Integrated
Standalone

By Deployment Type
On-premise
Cloud-based

By Component
Commercial
Public

By End User
Government & Third party
Research Centers
Hospital & Medical Centers
Private Payers
Pharma Biotech & Medical Device Suppliers

By Geography

North America
US
Canada
Mexico
Rest of North America

Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled
IBM Corporation
McKesson Corporation
Conduent, Incorporated
Elekta AB
Ordinal Data, Inc.
Onco, Inc.
C/Net Solutions
Rocky Mountain Cancer Data System
Electronic Registry System, Inc.
Himagine Solutions, Inc.